Get started
Work

Supplementary Figure 2 from Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody–Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or Enzalutamide

Year: 2023
Type: supplementary-materials
Abstract: Mutation profiles in ctDNA: truncating and/or pathogenic mutations in DDR or DDR-related pathway
DOI: 10.1158/1078-0432.22481342
Authors: Johann S. de Bono, Mark T. Fleming, Judy S. Wang, Richard Cathomas, Manuel Selvi Miralles, John Bothos, Mary Jane Hinrichs, Qu Zhang, Peng He, Marna Williams, Anton I. Rosenbaum, Meina Liang, Kapil Vashisht, Song Cho, Pablo Martinez, Daniel P. Petrylak
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361863387
Cites:
Cited by:
Related to: 10